CD274 and glioblastoma: Several studies have shown that high PD-L1 expression in GBM is associated with invasiveness, immuno-resistance, and an overall poor prognosis.4–8 Furthermore, PD-L1 was found to be significantly upregulated in the more aggressive and multitherapy-resistant mesenchymal subtype of GBM amongst other transcriptional subtypes.